ostrich
popul
densiti
result
intens
rear
increas
suscept
pathogen
mycoplasma
addit
good
manag
practic
vaccin
offer
attract
altern
control
mycoplasma
infect
food
anim
instead
use
antibiot
often
leav
unaccept
residu
use
live
attenu
vaccin
howev
carri
concern
revers
virul
genet
recombin
field
strain
current
commerci
avail
vaccin
ostrichinfect
mycoplasma
studi
therefor
set
develop
evalu
use
dna
vaccin
mycoplasma
infect
ostrich
use
oppa
protein
antigen
end
oppa
gene
mycoplasma
nasistruthioni
sp
nov
str
clone
two
dna
vaccin
express
vector
codon
correct
sitedirect
mutagenesi
threemonthsold
ostrich
vaccin
intramuscularli
differ
dose
follow
booster
vaccin
week
abil
dna
vaccin
elicit
antioppa
antibodi
respons
evalu
elisa
use
recombin
oppa
protein
coat
antigen
statist
signific
antioppa
antibodi
respons
could
detect
administr
booster
vaccin
indic
oppa
protein
success
immunogen
respons
also
dose
vector
depend
conclus
dna
vaccin
abl
elicit
immun
respons
ostrich
therefor
view
option
develop
vaccin
mycoplasma
infect
ostrich
struthio
camelu
var
domesticu
largest
live
flightless
bird
speci
belong
ratit
group
although
ostrich
tradit
endem
africa
part
arabia
middl
east
rear
sever
countri
across
world
south
africa
howev
current
largest
produc
ostrich
product
meat
leather
feather
intern
market
major
ostrich
destin
slaughter
rear
freerang
system
environment
condit
unfavor
graze
rear
growout
camp
month
age
mycoplasma
genu
bacteria
belong
prokaryot
class
mollicut
known
highli
infecti
intens
rear
system
characterist
featur
mycoplasma
includ
lack
cell
wall
small
atrich
genom
minim
set
gene
speci
found
specif
infect
ostrich
mycoplasma
struthioni
sp
nov
str
mycoplasma
sp
str
mycoplasma
nasistruthioni
sp
nov
str
typic
associ
upper
respiratori
tract
infect
reduc
growth
rate
downgrad
carcass
extrem
case
chick
mortal
sever
infect
increas
exposur
environment
induc
stress
bacteri
viral
infect
three
mycoplasma
speci
mycoplasma
nasistruthioni
sp
nov
str
found
highest
preval
amongst
ostrich
therefor
focu
studi
mycoplasma
infect
current
manag
use
combin
biosecur
system
antibiot
antibiot
risk
resist
well
accumul
residu
meat
concomit
risk
consum
develop
whole
organ
vaccin
use
ostrich
limit
slowgrow
natur
organ
cost
medium
requir
sustain
growth
dna
vaccin
hand
requir
larg
scale
cultiv
pathogen
produc
rel
low
cost
temperatur
stabl
vaccin
therefor
attract
altern
use
ostrich
vaccin
market
small
rel
eg
poultri
ostrich
usual
farm
semiarid
arid
region
temperatur
frequent
high
cold
storag
vaccin
problemat
similar
live
vaccin
also
abl
stimul
humor
cellular
immun
indic
measur
antibodi
thelper
cell
cytotox
tlymphocyt
respons
unlik
live
vaccin
revert
back
infecti
form
el
gazzar
et
al
report
revers
virul
commonli
use
live
mycoplasma
vaccin
poultri
whilst
anoth
report
possibl
genet
recombin
live
vaccin
field
strain
upon
long
term
use
exchang
transfer
gene
could
neg
impact
either
pathogen
transmiss
field
strain
chromosom
integr
dna
vaccin
concern
preclin
clinic
studi
shown
rate
integr
plasmid
dna
host
genom
lower
spontan
mutat
date
dna
vaccin
test
ostrich
ratit
aim
studi
use
oppa
protein
nasistruthioni
sp
nov
str
antigen
develop
evalu
dna
vaccin
ostrich
differ
dose
use
differ
vector
dna
vaccin
plasmid
express
vector
contain
gene
code
protein
antigen
result
parasit
lifestyl
mycoplasma
possess
reli
wide
rang
transmembran
transport
system
surviv
extracellular
compon
transport
ideal
target
vaccin
develop
studi
extracellular
oppa
domain
oligopeptid
permeas
opp
transport
chosen
protein
antigen
use
mous
model
oppa
date
evalu
antigen
subunit
vaccin
brachyspira
pilosicoli
moraxella
catarrhali
yersinia
pesti
well
haemophilu
parasui
pig
oppa
howev
evalu
organ
part
dna
vaccin
studi
report
first
time
dna
vaccin
elicit
humor
immun
respons
ostrich
use
oppa
antigen
respons
dose
vector
depend
sitedirect
mutagenesi
oppa
gene
cultur
nasistruthioni
sp
nov
str
genbank
obtain
mr
jj
gouw
faculti
veterinari
scienc
onderstepoort
univers
pretoria
genom
dna
gdna
isol
cultur
use
method
describ
hempstead
type
oppa
gene
pcineo
promega
vical
inc
chosen
vaccin
vector
supplementari
figur
pcineo
vector
mammalian
express
vector
contain
cmv
enhancerpromot
region
chimer
intron
late
polyadenyl
signal
sequenc
vector
also
contain
cmv
enhancerpromot
region
combin
cmv
intron
tissu
plasminogen
activ
tpa
signal
peptid
sequenc
bovin
growth
hormon
polyadenyl
signal
sequenc
mutat
oppa
gene
subclon
vector
use
restrict
digest
pcineo
acci
mlui
fastdigest
thermo
scientif
bamhi
fermenta
restrict
enzym
use
accord
manufactur
instruct
cultur
pcineooppa
vaccin
plasmid
prepar
respect
plasmid
purifi
endotoxinfre
plasmid
dna
purif
kit
nucleobond
r
xtra
midi
plu
ef
machereynagel
germani
yield
determin
use
nanodrop
spectrophotomet
prior
larg
scale
plasmid
isol
vaccin
nucleobond
kit
abil
yield
supercoil
pcineooppa
plasmid
evalu
digest
plasmid
acci
bamhi
restrict
enzym
respect
follow
electrophoresi
wv
agaros
gel
prepar
suffici
amount
plasmid
vaccin
plasmid
prepar
batch
sever
day
purifi
plasmid
evalu
confirm
integr
supercoil
plasmid
prior
use
vaccin
isol
plasmid
dilut
steril
pb
mm
nacl
mm
kcl
mm
na
hpo
mm
kh
po
ph
respect
day
use
dilut
prepar
asept
condit
steril
serum
glass
bottl
close
inert
silicon
stopper
seal
tear
away
center
aluminum
cap
sigmaaldrich
ethic
approv
obtain
stellenbosch
univers
anim
ethic
committe
suacum
well
south
african
depart
agricultur
forestri
fisheri
refer
term
section
anim
diseas
act
act
group
ostrich
chick
randomli
select
chick
rear
unit
fraserburg
district
northern
cape
provinc
south
africa
sinc
fraserburg
outsid
major
commerci
ostrich
product
region
limit
pathogen
exposur
critic
monthsold
rear
phase
per
standard
practic
upon
reach
weight
kg
month
age
trial
ostrich
transport
back
km
commerci
ostrich
farm
oudtshoorn
district
western
cape
provinc
south
africa
threemonthold
chick
chosen
vaccin
allow
suffici
time
primari
immun
respons
develop
transport
higher
stress
environ
concomit
increas
pathogen
load
increas
risk
exposur
mycoplasma
chick
quarantin
day
reloc
random
test
perform
avian
influenza
requir
avian
influenza
control
measur
ostrich
releas
allow
mix
popul
farm
transport
start
trial
ostrich
tag
uniqu
number
identif
right
wing
accord
standard
ostrich
farm
practic
trial
conduct
similar
condit
commerci
vaccin
would
administ
therefor
trial
ostrich
time
hous
treat
manner
nontrial
ostrich
farm
fraserburg
chick
rear
unit
open
air
camp
chick
per
camp
oudtshoorn
ostrich
kept
open
air
growout
camp
ostrich
per
camp
ostrich
receiv
food
water
ad
libitum
handl
train
experienc
farm
personnel
trial
bird
kept
separ
group
ostrich
weight
age
ostrich
randomli
alloc
seven
treatment
group
ostrich
pcineooppa
vaccin
group
vaccin
dose
respect
last
group
control
group
receiv
vaccin
dose
typic
administ
poultri
rang
inject
intramuscularli
booster
dose
week
dunham
indic
larger
anim
may
requir
larger
dose
need
optim
individu
vaccin
sinc
dose
requir
influenc
target
speci
size
effici
plasmid
deliveri
differ
dose
use
studi
therefor
select
compens
increas
weight
ostrich
cours
trial
fact
adjuv
use
vaccin
formul
limit
possibl
skin
reaction
impact
hide
qualiti
vaccin
dose
administ
singl
ml
volum
week
booster
inject
administ
week
intramuscular
inject
upper
thigh
blood
sampl
ml
drawn
jugular
vein
use
needl
vacuett
r
collect
vacuett
r
z
serum
sep
clot
activ
tube
week
serum
separ
centrifug
low
speed
min
store
c
week
sampl
collect
fraserburg
week
sampl
oudtshoorn
ostrich
move
fraserburg
oudtshoorn
day
prior
week
sampl
booster
inject
therefor
administ
quarantin
period
ostrich
monitor
vaccin
advers
reaction
analysi
antioppa
antibodi
respons
recombin
oppa
protein
produc
use
coat
antigen
enzymelink
immunosorb
assay
elisa
end
sdm
correct
oppa
gene
pcr
amplifi
subclon
vector
ge
healthcar
life
scienc
uk
use
restrict
digest
primer
sequenc
bamhi
noti
restrict
site
shown
supplementari
tabl
protein
express
plasmid
transform
escherichia
coli
plyss
cell
promega
freezer
stock
prepar
overnight
cultur
freezer
stock
express
cultur
prepar
use
terrificbroth
tb
medium
express
glutathion
stransferas
gst
oppa
fusion
protein
induc
od
addit
mm
iptg
cell
harvest
h
centrifug
g
c
cell
resuspend
extract
buffer
mm
trishcl
mm
edta
mm
nacl
triton
dithiothreitol
glycerol
vv
extract
buffer
per
ml
cultur
use
centrifug
proteas
inhibitor
also
ad
buffer
tablet
per
ml
extract
solut
complet
ultra
tablet
mini
easypack
tablet
roch
gstoppa
protein
isol
use
glutathioneagaros
chromatographi
sigmaaldrich
graviti
flow
c
accord
manufactur
instruct
sampl
ml
prepar
load
column
treat
resuspend
pellet
three
freezethaw
cycl
min
c
follow
min
c
five
cycl
sonic
follow
min
ice
sampl
tritur
three
time
needl
avacar
ml
injektf
syring
bbraun
repeat
use
needl
nipro
follow
centrifug
g
min
c
obtain
clear
supernat
load
onto
column
graviti
flow
c
fraction
ml
collect
protein
concentr
determin
use
modifi
bradford
assay
express
isol
product
analyz
use
sdspage
western
blot
analysi
microtit
plate
maxisorp
nunc
coat
overnight
c
recombin
gstoppa
protein
dilut
carbon
buffer
mm
nahco
ph
block
nonspecif
bind
casein
buffer
mm
trishcl
mm
nacl
casein
thiomers
ph
ad
plate
incub
h
c
serum
sampl
dilut
caseintween
casein
buffer
contain
vv
tween
r
ad
plate
triplic
incub
h
c
biotinyl
rabbit
antiostrich
ig
polyclon
antibodi
prepar
previous
describ
next
ad
dilut
caseintween
incub
h
c
streptavidin
horseradish
peroxidas
hrp
conjug
mixtur
ml
streptavidin
hrp
invitrogen
ml
casein
buffer
ml
glycerol
dilut
caseintween
ad
plate
incub
h
c
final
substrat
solut
mgml
abt
h
citrat
buffer
ph
ad
absorb
measur
nm
thermo
scientif
multiskan
ex
plate
reader
min
incub
c
incub
step
content
plate
first
decant
follow
wash
five
time
pbstween
mm
nacl
mm
kcl
mm
na
hpo
mm
kh
po
ph
vv
tween
r
wash
three
time
milliq
r
water
coat
block
step
wash
appli
firstrow
column
blank
contain
compon
except
ostrich
serum
use
plate
blank
absorb
valu
plate
contain
control
monitor
plate
plate
variat
control
serum
sampl
repres
week
sampl
point
singl
ostrich
randomli
select
pcineooppa
group
base
high
titer
produc
vaccin
prior
analysi
sampl
elisa
optim
regard
coat
concentr
serum
dilut
well
number
wash
cycl
step
nonspecif
bind
antioppa
antibodi
elisa
analysi
evalu
coat
well
carbon
buffer
contain
captur
antigen
serum
vaccin
bird
gave
high
absorb
valu
dilut
use
gstoppa
protein
captur
antigen
absorb
valu
obtain
refer
elisa
titr
measur
antibodi
level
produc
use
serum
dilut
elisa
weight
trial
bird
monitor
record
week
determin
possibl
influenc
exist
mycoplasma
infect
immun
respons
data
trachea
swab
collect
week
test
presenc
mycoplasma
infect
pcr
bird
howev
exclud
trial
test
posit
sinc
ostrich
often
natur
infect
mycoplasma
swab
sampl
collect
use
dri
steril
swab
copan
rins
steril
pb
buffer
eluat
test
pcr
use
gener
primer
pair
specif
mycoplasma
genu
posit
sampl
evalu
presenc
ostrichinfect
mycoplasma
statist
analysi
elisa
titer
data
perform
use
gener
linear
model
glm
procedur
agrobas
gener
ii
r
agronomix
softwar
inc
softwar
analysi
varianc
anova
least
signific
differ
lsd
valu
calcul
signific
level
bp
oppa
gene
success
amplifi
gdna
clone
pgem
r
easi
vector
confirm
sequenc
use
sdm
mycoplasma
tga
codon
plasmid
success
mutat
univers
tgg
codon
seven
consecut
step
sdm
confirm
sequenc
supplementari
figur
mutat
oppa
gene
success
subclon
pcineo
vaccin
vector
confirm
sequenc
supplementari
figur
larg
scale
product
dna
vaccin
achiev
approxim
mg
plasmid
isol
pcineooppa
absorb
ratio
isol
plasmid
rang
integr
isol
plasmid
confirm
agaros
electrophoresi
pdna
requir
supercoil
conform
supercoil
conform
higher
transfect
rate
mammalian
cell
less
suscept
intracellular
degrad
effect
induc
immun
respons
plasmid
conform
ostrich
vaccin
prepar
dna
vaccin
advers
reaction
observ
inject
site
red
swell
inflamm
allerg
reaction
trial
ostrich
resum
normal
behavior
eat
walk
around
explor
immedi
vaccin
lame
loss
appetit
subclon
mutat
oppa
gene
vector
success
confirm
sequenc
frontier
immunolog
wwwfrontiersinorg
supplementari
figur
sdspage
western
blot
analys
confirm
recombin
oppa
protein
express
success
ntermin
gstfusion
protein
predict
size
kda
kda
due
gst
tag
figur
b
bradford
analysi
indic
oppa
protein
elut
fraction
highest
concentr
obtain
fraction
ostrich
two
miss
sampl
point
exclud
elisa
subsequ
statist
analysi
nonspecif
bind
antioppa
antibodi
ostrich
serum
plate
control
sampl
indic
limit
plate
plate
variat
titer
valu
result
vaccin
pcineooppa
vaccin
shown
figur
b
respect
titer
valu
control
group
receiv
vaccin
show
signific
variat
time
howev
slight
increas
averag
titer
week
vaccin
pcineooppa
vaccin
figur
result
signific
treatment
x
time
interact
p
dose
result
averag
elisa
titer
differ
significantli
control
also
week
booster
vaccin
administ
averag
titer
differ
dose
howev
significantli
differ
one
anoth
vaccin
vaccin
figur
result
signific
treatment
time
interact
p
three
dose
result
averag
elisa
titer
differ
significantli
lsd
control
week
booster
vaccin
administ
dose
differ
significantli
one
anoth
vaccin
group
well
control
group
gain
weight
week
week
averag
weight
loss
kg
tabl
howev
statist
signific
differ
treatment
group
control
group
week
period
p
pcineooppa
p
presenc
mycoplasma
infect
monitor
pcr
trial
tabl
mycoplasma
infect
could
detect
group
week
infect
howev
detect
week
point
ostrich
oudtshoorn
day
day
quarantin
group
receiv
vaccin
highest
percentag
infect
week
due
follow
tabl
compar
group
receiv
pcineooppa
vaccin
fewer
mycoplasma
infect
amongst
highest
percentag
infect
due
follow
vaccin
group
bird
infect
one
mycoplasma
speci
group
pcrdetect
mycoplasma
infect
week
group
receiv
vaccin
control
group
studi
dna
vaccin
develop
ostrich
use
oppa
gene
ostrichinfect
mycoplasma
vaccin
antigen
express
vector
use
pcineo
select
base
dna
vaccin
studi
bird
immunostimulatori
characterist
vaccin
chick
statist
signific
antioppa
antibodi
respons
could
detect
week
although
gener
trend
increas
averag
titer
valu
observ
week
group
receiv
vaccin
base
previou
studi
use
inactiv
vaccin
ostrich
expect
primari
immun
respons
week
first
vaccin
ie
week
administ
booster
vaccin
dna
vaccin
abl
elicit
statist
signific
antioppa
antibodi
respons
respons
oppa
signific
comparison
neg
respons
follow
first
vaccin
evid
secondari
immun
respons
result
immun
memori
memori
cell
produc
initi
contact
antigen
subsequ
exposur
antigen
allow
host
recogn
antigen
faster
greater
magnitud
respons
elicit
dna
vaccin
howev
dose
depend
well
vector
depend
sinc
differ
result
produc
vaccin
use
dose
highlight
possibl
role
vaccin
vector
observ
antibodi
respons
vaccin
averag
elicit
higher
titer
valu
compar
pcineooppa
vaccin
might
due
tpa
signal
sequenc
plasmid
situat
upstream
oppa
gene
assist
protein
express
mammalian
cell
export
protein
cell
would
turn
increas
immunogen
antigen
addit
sequenc
plasmid
backbon
intrins
immunostimulatori
activ
enhanc
immun
system
respons
express
protein
antigen
whole
vaccin
trial
health
ostrich
monitor
record
weight
gain
group
gain
weight
week
toward
week
weight
gain
decreas
given
trend
also
observ
control
group
ostrich
weight
loss
ascrib
vaccin
decreas
weight
howev
coincid
movement
bird
new
locat
ostrich
known
sever
affect
stress
period
adapt
chang
social
dynam
hous
environ
reduct
weight
gain
even
weight
loss
normal
amongst
farm
ostrich
presenc
exist
mycoplasma
infect
start
trial
well
chang
infect
statu
trial
also
monitor
pcr
analysi
trachea
swab
mycoplasma
infect
could
detect
week
move
expos
farm
environ
oudtshoorn
day
absenc
detect
mycoplasma
infect
earlier
time
point
may
ascrib
fraserburg
outsid
commerci
ostrich
product
region
oudtshoorn
district
hand
higher
incid
mycoplasma
infect
especi
season
chang
trial
conduct
late
autumn
amongst
vaccin
group
number
detect
infect
low
compar
control
group
detect
ostrichinfect
mycoplasma
futur
trial
care
consider
given
time
primari
booster
vaccin
rel
time
introduct
growout
condit
possibl
mycoplasma
infect
influenc
observ
antibodi
respons
studi
done
yang
et
al
use
recombin
oppa
protein
subunit
vaccin
catarrhali
mice
found
elisa
titer
valu
alreadi
rais
start
vaccin
trial
ascrib
presenc
exist
system
antibodi
oppa
result
exist
infect
despit
possibl
presenc
antibodi
due
mycoplasma
infect
mask
detect
dose
depend
antibodi
respons
oppa
protein
vaccin
conclus
first
studi
show
dna
vaccin
abl
elicit
antibodi
respons
ostrich
mycoplasma
antigen
spite
ostrich
prone
environment
induc
stress
condit
suppress
immun
function
mycoplasma
oppa
protein
suffici
immunogen
induc
antioppa
antibodi
respons
respons
firstli
dose
depend
secondli
requir
booster
vaccin
trial
requir
determin
extent
protect
provid
mycoplasma
antigen
rel
time
primari
booster
vaccin
introduct
growout
condit
studi
field
trial
carri
accord
recommend
south
african
depart
agricultur
forestri
fisheri
refer
term
section
anim
diseas
act
act
protocol
approv
stellenbosch
univers
anim
ethic
committe
suacum
mw
perform
sdm
prepar
dna
vaccin
express
plasmid
optim
express
recombin
oppa
protein
initi
optim
elisa
hj
optim
elisa
evalu
antioppa
antibodi
respons
vaccin
trial
ao
assist
vaccin
trial
mw
wrote
manuscript
support
ab
ab
supervis
project
assist
db
ao
ab
db
conceiv
origin
idea
author
provid
critic
feedback
help
shape
research
analysi
manuscript
work
support
technolog
human
resourc
industri
programm
thrip
south
africa
project
refer
south
african
ostrich
busi
chamber
would
like
thank
vical
inc
usa
suppli
vector
research
purpos
mr
j
j
gouw
faculti
veterinari
scienc
onderstepoort
univers
pretoria
cultur
mycoplasma
bacteria
supplementari
materi
articl
found
onlin
http
supplementarymateri
